Tag archive for ‘Mori Arkin’
Jewish Business News On Monday, May 16th, 2016

Israeli leukemia treatment co BioSight raises $13 million

  BioSight,  an Israeli pharmaceutical development company has closed a $13 million financing round led by the Mori Arkin’s pharmaceutical investment firm, Arkin Holdings, and the US based venture More...

Viva Sarah Press On Wednesday, March 2nd, 2016

17 Israeli billionaires make annual Forbes rich list

  Seventeen Israeli billionaires made the 30th Forbes Billionaires List for 2016, including newcomer Adam Neumann, cofounder of shared work space firm WeWork. The kibbutz-raised Neumann is spotlighted among More...

Niva Goldberg On Friday, September 11th, 2015

Perrigo CEO calls Mylan offer ‘grossly inadequate’; Israeli shareholder rejects the bid

  Trying to fend off a hostile takeover attempt by Mylan’s $27 billion bid, Perrigo Chairman, President and CEO Joseph Papa sent a letter to Mylan Executive Chairman Robert Coury to ‘clarifying More...

Gil Tanenbaum On Wednesday, October 29th, 2014

Medical Device Maker Endochoice Eyeing $150 Million IPO

Endochoice, a company which produces all manner of medical devices, is planning a NASDAQ IPO for 2015 which it hopes will bring in $100 to $150 Million. The firm merged with Israel’s endoscopic company More...

Gali Weinreb On Wednesday, September 10th, 2014

Investor files class action on Andromeda biotech

– Investor Mori Arkin: If Hyperion overlooked weak points in the data, it’s their mistake. – The Andromeda affair, in which an Israeli company is being accused of forging clinical More...

S.M. Lightening On Monday, July 21st, 2014

Report: Mori Arkin to Buy Zit Fighting Company for $10M

– Sol-Gel’s patented control processes enable the development of improved drug delivery capabilities. – Israeli billionaire businessman Mori Arkin is in talks to buy Sol-Gel Technologies, a More...

Gali Weinreb On Thursday, July 17th, 2014

Mori Arkin in talks to acquire Sol-Gel

  Sol-Gel is trying to improve acne and rosacea treatments using nanoscale particles.   Businessman Mori Arkin is in advanced talks to buy Sol-Gel, which is developing skincare products using nanotechnology, More...

Globes On Saturday, July 27th, 2013

Exalenz Bioscience raises NIS 28 million ($ 7.7 million) in rights issue

– The company has developed the BreathID device for diagnosis diseases of the digestive tract from a patient’s breath. – / By Gali Weinreb / Exalenz Bioscience Ltd. (TASE:EXEN) completed on More...

Ilan Shavit On Thursday, June 27th, 2013

The Technological Incubators Program chose the three best technology incubator graduate companies

– TheTime is Israel’s best technology incubator.  The Technological Incubators Program has also chosen the three best technology incubator graduate companies, to be presented at its annual convention. – – /By More...

Wordpress site Developed by Fixing WordPress Problems